ImageVerifierCode 换一换
格式:PPT , 页数:13 ,大小:256.50KB ,
资源ID:1295091      下载积分:10 文钱
快捷下载
登录下载
邮箱/手机:
温馨提示:
快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。 如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

加入VIP,省得不是一点点
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.wenke99.com/d-1295091.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: QQ登录   微博登录 

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(围手术期抗血小板策略项美香.ppt)为本站会员(h****)主动上传,文客久久仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知文客久久(发送邮件至hr@wenke99.com或直接QQ联系客服),我们立即给予删除!

围手术期抗血小板策略项美香.ppt

1、 ACC/AHA/SCAI Focused Update of the Guideline for Percutaneous Coronary Intervention2007 Writing Committee MembersSpencer B. King III, MD, MACC, FAHA, FSCAI, Co-ChairSidney C. Smith, MD, FACC, FAHA, Co-ChairJohn W. Hirshfeld, Jr, MD, FACC, FAHA, FSCAIAlice K. Jacobs, MD, FACC, FAHA, FSCAIDouglass A.

2、 Morrison, MD, PhD, FACC, FSCAIDavid O. Williams, MD, FACC, FAHA, FSCAIAntiplatelet TherapyA loading dose of clopidogrel, generally 600 mg, should be administered before or when PCI is performed. Modified recommendationIn patients undergoing PCI within 12 to 24 hours of receiving fibrinolytic therap

3、y, a clopidogrel oral loading dose of 300mg may be considered.Modified recommendationFor all post-PCI stented patients receiving a DES, clopidogrel 75 mg daily should be given for at least 12 months if not at high risk of bleeding.Modified recommendationFor patients receiving BMS, clopidogrel should

4、 be given for a minimum of 1 month and ideally up to 12 months (unless at increased risk of bleeding).Modified recommendationI IIaIIa IIbIbII IIIIIII IIa IIb IIII IIa IIb IIII IIaIIa IIbIbII IIIIIIAntiplatelet TherapyIf clopidogrel is given at the time of procedure, supplementation with GP IIb/IIIa

5、receptor antagonists can be beneficial.ModifiedFor patients with an absolute contraindication to aspirin, it is reasonable to give a 300 mg to 600 mg loading dose of clopidogrel, administered at least 6 hours before PCI, and/or GP IIa/IIIa antagonists at the time of PCI.No ChangeIn patients with inc

6、reased risk of bleeding, a lower dose of 75 mg to 162 mg of aspirin is reasonable during the initial period after stent implantation.NewContinuation of clopidogrel therapy beyond 1 year may be considered in patients undergoing DES placement.NewI IIaIIaIIaIIbIIIIIIIIbI I II IIaIIbIIII IIa IIb IIII II

7、aIIbIIIAntiplatelet TherapyPatients already taking daily long-term aspirin should take 75 mg to 325 mg before PCI.No changesPatients not already taking daily aspirin should be given 300 mg to 325 mg of aspirin at least 2 hours and preferably 24 hours before PCI.No changeAfter PCI, in patients withou

8、t allergy or increased risk of bleeding, aspirin 162 mg to 325 mg daily should be given for at least:1 month after BMS3 months after sirolimus-eluting stent6 months after paclitaxel-eluting stentModified recommendationI IIa IIb IIII IIaIIbIIII IIa IIb IIIAspirinAll post-PCI stented patients without

9、aspirin resistance, allergy, or increased risk of bleeding should be given aspirin 162 mg to 325 mg daily for at least:1 month after BMS 3 months after sirolimus-eluting stent6 months after paclitaxel-eluting stent Long-term aspirin use should be continued indefinitely at 75 mg to 162 mg daily.Modif

10、ied recommendationIn patients at increased risk of bleeding, lower-dose 75 mg to 162 mg of aspirin is reasonable during the initial period after stent implantation.New recommendationII IIaIIII IIbIIIIb IIIIIII IIaIIbIIIAspirin 2006 Consensus of China: ASA100300mg q.d. after PCI at least 1 month. And

11、 then 75100mg q.d. Aspirin No trials compared lower dose(75-162mg) with higher dose aspirin (162-325mg) as the initial course of therapy after DES in subacute or late stent thrombosis The recommendation according to the clinical trial protocol Higher dose aspirin increase the risk of bleeding In the

12、 patients at high risk of bleeding, the use of low dose of aspirin.Aspirin Major bleeding events were more frequently in patients of taking SA 200mg+clopidogrel 75mg than that of taking ASA 100mg + clopidogrel 75mg Antiplatelet effects could not be increased in higher dose of ASA ClopidogrelFor all

13、post-PCI patients who receive a DES, clopidogrel 75 mg daily should be given for at least 12 months if not at high risk of bleeding.For post-PCI patients receiving as BMS, it should be given for a minimum of 1 month and ideally up to 12 months (unless patient is at increased risk of bleeding then it

14、 should be given for a minimum of 2 weeks).Modified recommendationFor all post-PCI non-stented STEMI patients, treatment with clopidogrel should continue for 14 days.New recommendationLong-term maintenance therapy (e.g. 1 year) with clopidogrel is reasonable in STEMI and NSTEMI who undergo PCI without reperfusion therapy. New recommendationII IIaII IIbII IIIIIII IIaIIbIIIII IIaII IIbII IIIIIIPerioperative period Under urgent situation, the duration studied for FDA approval 3 months for SES6 months for PES

Copyright © 2018-2021 Wenke99.com All rights reserved

工信部备案号浙ICP备20026746号-2  

公安局备案号:浙公网安备33038302330469号

本站为C2C交文档易平台,即用户上传的文档直接卖给下载用户,本站只是网络服务中间平台,所有原创文档下载所得归上传人所有,若您发现上传作品侵犯了您的权利,请立刻联系网站客服并提供证据,平台将在3个工作日内予以改正。